rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
6
|
pubmed:dateCreated |
2010-6-10
|
pubmed:abstractText |
To evaluate the safety and efficacy of abatacept in patients with severe juvenile idiopathic arthritis (JIA)-related uveitis refractory or intolerant to immunosuppressive and anti-tumor necrosis factor alpha (anti-TNFalpha) agents.
|
pubmed:commentsCorrections |
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Jun
|
pubmed:issn |
2151-4658
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
62
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
821-5
|
pubmed:dateRevised |
2011-2-25
|
pubmed:meshHeading |
pubmed-meshheading:20191477-Adolescent,
pubmed-meshheading:20191477-Antirheumatic Agents,
pubmed-meshheading:20191477-Arthritis, Juvenile Rheumatoid,
pubmed-meshheading:20191477-Child,
pubmed-meshheading:20191477-Child, Preschool,
pubmed-meshheading:20191477-Female,
pubmed-meshheading:20191477-Follow-Up Studies,
pubmed-meshheading:20191477-Humans,
pubmed-meshheading:20191477-Immunoconjugates,
pubmed-meshheading:20191477-Male,
pubmed-meshheading:20191477-Tumor Necrosis Factor-alpha,
pubmed-meshheading:20191477-Uveitis
|
pubmed:year |
2010
|
pubmed:articleTitle |
Abatacept for severe anti-tumor necrosis factor alpha refractory juvenile idiopathic arthritis-related uveitis.
|
pubmed:affiliation |
University of Padua, Padua, Italy. zulian@pediatria.unipd.it
|
pubmed:publicationType |
Journal Article,
Comparative Study
|